Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Pneumococcal Carriage and Disease in Adults in England, 2011–2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities
El Safadi D. et al, (2025), The Journal of Infectious Diseases, 231, e17 - e27
A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia
Viz-Lasheras S. et al, (2025), iScience, 28, 111747 - 111747
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment
Viz-Lasheras S. et al, (2025), Nature Communications, 16
Evaluation of naturally occurring IgG anti-Vi antibody titers as predictors and correlates of typhoid fever in Dhaka, Bangladesh.
Khanam F. et al, (2025), BMC infectious diseases, 25
Predictors of severity of SARS-CoV-2 infections in Brazil: Post hoc analyses of a randomised controlled trial
Conlin K. et al, (2025), Vaccine, 45, 126582 - 126582
Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study.
Feng S. et al, (2025), The Journal of infection, 90
The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in children.
Kristensen M. et al, (2024), Cell reports. Medicine, 5
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.
Terstappen J. et al, (2024), The Lancet. Infectious diseases, 24, e747 - e761
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference.
Amodio D. et al, (2024), Vaccine, 43
GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies.
Lin L. et al, (2024), PLoS computational biology, 20
New programme to prevent bronchiolitis in infants
Pollard AJ. et al, (2024), Archives of Disease in Childhood
5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial
Qadri F. et al, (2024), The Lancet, 404, 1419 - 1429
Oxford Vaccine Hesitancy Scale (OVHS): a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess vaccine hesitancy
Kantor J. et al, (2024), BMJ Open, 14, e084669 - e084669
Respiratory Syncytial Virus-related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort Study.
Wiseman DJ. et al, (2024), American journal of respiratory and critical care medicine, 210, 994 - 1001
A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens.
Pinto MV. et al, (2024), Journal of immunological methods, 534
Changes to the UK childhood immunisation schedule.
Akeju O. et al, (2024), Archives of disease in childhood
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
Naghavi M. et al, (2024), The Lancet, 404, 1199 - 1226
What have we learned from animal studies of immune responses to respiratory syncytial virus infection?
Drysdale SB. et al, (2024), Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 175